4.8 Editorial Material

Identifying and targeting the Achilles heel of a recalcitrant cancer

Journal

SCIENCE TRANSLATIONAL MEDICINE
Volume 13, Issue 605, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.abj6946

Keywords

-

Funding

  1. National Institutes of Health/National Cancer Institute [R01 CA258784]
  2. Druckenmiller Center for Lung Cancer Research
  3. Memorial Sloan Kettering Cancer Center
  4. Parker Institute for Cancer Immunotherapy
  5. Congressionally Directed Medical Research Programs/Lung Cancer Research Programs Investigator-Initiated Translational Research Award
  6. Lung Cancer Foundation of America/Bristol Myers Squibb/International Lung Cancer Foundation Young Investigator Award in Translational Immuno-oncology
  7. Lung Cancer Research Foundation

Ask authors/readers for more resources

Targeting replication stress response proteins in small cell lung cancer can activate the innate immune cGAS-STING pathway, leading to enhanced antitumor response of immunotherapy.
Targeting replication stress response proteins in small cell lung cancer activates the innate immune cGAS-STING pathway leading to augmentation of immunotherapy's antitumor response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available